The thrombectomy devices market size has grown strongly in recent years. It will grow from $1.64 billion in 2025 to $1.78 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising incidence of ischemic stroke cases, increasing availability of specialized stroke centers, improvements in catheter-based intervention techniques, growing clinician awareness of thrombectomy benefits, expansion of neurointerventional training programs.
The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of thrombectomy in wider patient populations, growing demand for faster reperfusion outcomes, expansion of advanced neurovascular infrastructure, rising investments in next-generation thrombectomy devices, increasing focus on combination therapy approaches. Major trends in the forecast period include increasing adoption of aspiration-based thrombectomy techniques, rising use of stent retriever devices, growing focus on rapid stroke intervention protocols, expansion of minimally invasive neurovascular procedures, enhanced device precision and trackability.
The growing aging population is expected to drive the growth of the thrombectomy devices market in the coming years. An aging population refers to a demographic trend marked by an increasing proportion of elderly individuals within a society over time. Thrombectomy devices are essential for managing health conditions common in the aging population, including stroke, coronary artery disease, aortic thrombosis, and deep vein thrombosis (DVT). For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Thus, the growing aging population is fueling growth in the thrombectomy devices market.
Major players in the thrombectomy devices market are dedicated to creating innovative solutions, such as arterial thrombectomy systems. An arterial thrombectomy system is a medical device specifically crafted for removing blood clots (thrombi) from arteries. For instance, in June 2023, Penumbra, Inc., a US-based healthcare company, unveiled the 'Lightning Bolt 7,' a new arterial thrombectomy system designed for efficient blood clot removal from arteries. The system incorporates pressure sensors paired with an algorithm, facilitating the removal of large and fibrous blood clots from arteries with minimal blood loss. It is employed to address conditions where a blockage hinders blood flow to organs such as the intestines, spleen, limbs, and liver. The integration of computer-aided components not only enhances safety but also encourages a preference for an endovascular-first approach in a broader range of cases, prioritizing it over open surgery.
In May 2024, GTCR, a private equity firm based in the U.S., acquired Surmodics for an undisclosed amount. This acquisition is intended to bolster Surmodics' growth, support its innovation in medical technologies, enhance shareholder value, and utilize synergies to expand its market presence, while transitioning the company to a private structure for a more strategic focus. Surmodics specializes in drug delivery technologies, in vitro diagnostic (IVD) products, medical device coatings, and thrombectomy devices.
Major companies operating in the thrombectomy devices market are Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Inari Medical Inc., BTG International Ltd., Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Rapid Medical, Neuravi Limited, Arteria Therapeutics Inc., Johnson and Johnson, Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, C. R. Bard Inc., Walk Vascular LLC, Kaneka Corporation, Baxter International.
North America was the largest region in the thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global thrombectomy devices market report during the forecast period. The regions covered in the thrombectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the thrombectomy devices market by increasing costs of imported precision catheters, nitinol components, imaging-compatible materials, and advanced manufacturing equipment used in aspiration and mechanical thrombectomy systems. Hospitals and stroke centers in North America and Europe are most affected due to reliance on specialized imported devices, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are increasing procedural costs and procurement expenses. However, they are also encouraging localized device manufacturing, regional supplier partnerships, and innovation in cost-efficient thrombectomy technologies.
The thrombectomy devices market research report is one of a series of new reports that provides thrombectomy devices market statistics, including thrombectomy devices industry global market size, regional shares, competitors with a thrombectomy devices market share, detailed thrombectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the thrombectomy devices industry. This thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Thrombectomy devices are utilized for vacuum aspiration to eliminate occlusive clots in acute ischemic stroke. Surgical thrombectomy involves the extraction or suctioning out of the clot using a specially designed clot removal device introduced through a catheter, aiming to restore blood flow.
The primary types of thrombectomy devices include aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices, and others. Aspiration thrombectomy devices are medical instruments designed for the removal of blood clots or thrombi from blood vessels. These devices find application in various areas such as cardiovascular, peripheral, and neurovascular applications, and are utilized by entities such as hospitals, surgical centers, ambulatory care facilities, academia, and contract research organizations (CROs).
The thrombectomy devices market consists of sales of mechanical thrombectomy, and aspiration thrombectomy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The thrombectomy devices market size is expected to see strong growth in the next few years. It will grow to $2.48 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing adoption of thrombectomy in wider patient populations, growing demand for faster reperfusion outcomes, expansion of advanced neurovascular infrastructure, rising investments in next-generation thrombectomy devices, increasing focus on combination therapy approaches. Major trends in the forecast period include increasing adoption of aspiration-based thrombectomy techniques, rising use of stent retriever devices, growing focus on rapid stroke intervention protocols, expansion of minimally invasive neurovascular procedures, enhanced device precision and trackability.
The growing aging population is expected to drive the growth of the thrombectomy devices market in the coming years. An aging population refers to a demographic trend marked by an increasing proportion of elderly individuals within a society over time. Thrombectomy devices are essential for managing health conditions common in the aging population, including stroke, coronary artery disease, aortic thrombosis, and deep vein thrombosis (DVT). For example, in October 2025, the World Health Organization (WHO), a Switzerland-based UN agency, projected that by 2030, one in six people globally will be aged 60 or older, with this population expected to double to 2.1 billion by 2050. Thus, the growing aging population is fueling growth in the thrombectomy devices market.
Major players in the thrombectomy devices market are dedicated to creating innovative solutions, such as arterial thrombectomy systems. An arterial thrombectomy system is a medical device specifically crafted for removing blood clots (thrombi) from arteries. For instance, in June 2023, Penumbra, Inc., a US-based healthcare company, unveiled the 'Lightning Bolt 7,' a new arterial thrombectomy system designed for efficient blood clot removal from arteries. The system incorporates pressure sensors paired with an algorithm, facilitating the removal of large and fibrous blood clots from arteries with minimal blood loss. It is employed to address conditions where a blockage hinders blood flow to organs such as the intestines, spleen, limbs, and liver. The integration of computer-aided components not only enhances safety but also encourages a preference for an endovascular-first approach in a broader range of cases, prioritizing it over open surgery.
In May 2024, GTCR, a private equity firm based in the U.S., acquired Surmodics for an undisclosed amount. This acquisition is intended to bolster Surmodics' growth, support its innovation in medical technologies, enhance shareholder value, and utilize synergies to expand its market presence, while transitioning the company to a private structure for a more strategic focus. Surmodics specializes in drug delivery technologies, in vitro diagnostic (IVD) products, medical device coatings, and thrombectomy devices.
Major companies operating in the thrombectomy devices market are Stryker Corporation, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, Penumbra Inc., Abbott Laboratories, Inari Medical Inc., BTG International Ltd., Phenox GmbH, Acandis GmbH & Co. KG, Straub Medical AG, MicroVention Inc., Rapid Medical, Neuravi Limited, Arteria Therapeutics Inc., Johnson and Johnson, Edwards Lifesciences Corporation, Argon Medical Devices Inc., Teleflex Incorporated, AngioDynamics, Koninklijke Philips NV, Spectranetics Corporation, C. R. Bard Inc., Walk Vascular LLC, Kaneka Corporation, Baxter International.
North America was the largest region in the thrombectomy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global thrombectomy devices market report during the forecast period. The regions covered in the thrombectomy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the thrombectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the thrombectomy devices market by increasing costs of imported precision catheters, nitinol components, imaging-compatible materials, and advanced manufacturing equipment used in aspiration and mechanical thrombectomy systems. Hospitals and stroke centers in North America and Europe are most affected due to reliance on specialized imported devices, while Asia-Pacific faces cost pressures in device manufacturing and distribution. These tariffs are increasing procedural costs and procurement expenses. However, they are also encouraging localized device manufacturing, regional supplier partnerships, and innovation in cost-efficient thrombectomy technologies.
The thrombectomy devices market research report is one of a series of new reports that provides thrombectomy devices market statistics, including thrombectomy devices industry global market size, regional shares, competitors with a thrombectomy devices market share, detailed thrombectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the thrombectomy devices industry. This thrombectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Thrombectomy devices are utilized for vacuum aspiration to eliminate occlusive clots in acute ischemic stroke. Surgical thrombectomy involves the extraction or suctioning out of the clot using a specially designed clot removal device introduced through a catheter, aiming to restore blood flow.
The primary types of thrombectomy devices include aspiration thrombectomy devices, mechanical thrombectomy devices, ultrasonic thrombectomy devices, and others. Aspiration thrombectomy devices are medical instruments designed for the removal of blood clots or thrombi from blood vessels. These devices find application in various areas such as cardiovascular, peripheral, and neurovascular applications, and are utilized by entities such as hospitals, surgical centers, ambulatory care facilities, academia, and contract research organizations (CROs).
The thrombectomy devices market consists of sales of mechanical thrombectomy, and aspiration thrombectomy. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Thrombectomy Devices Market Characteristics
3. Thrombectomy Devices Market Supply Chain Analysis
4. Global Thrombectomy Devices Market Trends and Strategies
5. Thrombectomy Devices Market Analysis of End Use Industries
7. Global Thrombectomy Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Thrombectomy Devices Total Addressable Market (TAM) Analysis for the Market
9. Thrombectomy Devices Market Segmentation
10. Thrombectomy Devices Market Regional and Country Analysis
11. Asia-Pacific Thrombectomy Devices Market
12. China Thrombectomy Devices Market
13. India Thrombectomy Devices Market
14. Japan Thrombectomy Devices Market
15. Australia Thrombectomy Devices Market
16. Indonesia Thrombectomy Devices Market
17. South Korea Thrombectomy Devices Market
18. Taiwan Thrombectomy Devices Market
19. South East Asia Thrombectomy Devices Market
20. Western Europe Thrombectomy Devices Market
21. UK Thrombectomy Devices Market
22. Germany Thrombectomy Devices Market
23. France Thrombectomy Devices Market
24. Italy Thrombectomy Devices Market
25. Spain Thrombectomy Devices Market
26. Eastern Europe Thrombectomy Devices Market
27. Russia Thrombectomy Devices Market
28. North America Thrombectomy Devices Market
29. USA Thrombectomy Devices Market
30. Canada Thrombectomy Devices Market
31. South America Thrombectomy Devices Market
32. Brazil Thrombectomy Devices Market
33. Middle East Thrombectomy Devices Market
34. Africa Thrombectomy Devices Market
36. Thrombectomy Devices Market Competitive Landscape and Company Profiles
37. Thrombectomy Devices Market Other Major and Innovative Companies
40. Thrombectomy Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Thrombectomy Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses thrombectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for thrombectomy devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thrombectomy devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product Type: Aspiration Thrombectomy Devices; Mechanical Thrombectomy Devices2) By Application: Neurovascular Applications; Peripheral Vascular Applications; Cardiovascular Applications
3) By End-User: Hospitals; Comprehensive Stroke Centers; Tertiary Care Centers
Subsegments:
1) By Aspiration Thrombectomy Devices: Manual Aspiration Devices; Powered Aspiration Devices2) By Mechanical Thrombectomy Devices: Stent Retriever Devices; Balloon Thrombectomy Devices
Companies Mentioned: Stryker Corporation; Medtronic plc; Boston Scientific Corporation; Terumo Corporation; Penumbra Inc.; Abbott Laboratories; Inari Medical Inc.; BTG International Ltd.; Phenox GmbH; Acandis GmbH & Co. KG; Straub Medical AG; MicroVention Inc.; Rapid Medical; Neuravi Limited; Arteria Therapeutics Inc.; Johnson and Johnson; Edwards Lifesciences Corporation; Argon Medical Devices Inc.; Teleflex Incorporated; AngioDynamics; Koninklijke Philips NV; Spectranetics Corporation; C. R. Bard Inc.; Walk Vascular LLC; Kaneka Corporation; Baxter International
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Thrombectomy Devices market report include:- Stryker Corporation
- Medtronic plc
- Boston Scientific Corporation
- Terumo Corporation
- Penumbra Inc.
- Abbott Laboratories
- Inari Medical Inc.
- BTG International Ltd.
- Phenox GmbH
- Acandis GmbH & Co. KG
- Straub Medical AG
- MicroVention Inc.
- Rapid Medical
- Neuravi Limited
- Arteria Therapeutics Inc.
- Johnson and Johnson
- Edwards Lifesciences Corporation
- Argon Medical Devices Inc.
- Teleflex Incorporated
- AngioDynamics
- Koninklijke Philips NV
- Spectranetics Corporation
- C. R. Bard Inc.
- Walk Vascular LLC
- Kaneka Corporation
- Baxter International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.78 Billion |
| Forecasted Market Value ( USD | $ 2.48 Billion |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 27 |
